GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Loans Receivable

Firebrick Pharma (ASX:FRE) Loans Receivable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Loans Receivable?

Firebrick Pharma's Loans Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Firebrick Pharma Loans Receivable Historical Data

The historical data trend for Firebrick Pharma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Loans Receivable Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Loans Receivable
- - - -

Firebrick Pharma Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Loans Receivable Get a 7-Day Free Trial - - - - -

Firebrick Pharma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Firebrick Pharma Loans Receivable Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines